A randomized double-blind study assessing 4 versus 8 mg. doxazosin for benign prostatic hyperplasia.

Purpose: We compare the efficacy of 4 versus 8 mg. doxazosin for benign prostatic hyperplasia.

Materials And Methods: A total of 82 patients with benign prostatic hyperplasia successfully treated with 4 mg.